The closing price of Definitive Healthcare Corp (NASDAQ: DH) was $9.31 for the day, up 1.75% from the previous closing price of $9.15. In other words, the price has increased by $+0.16 from its previous closing price. On the day, 554745 shares were traded.
Ratios:
Our analysis of DH’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.53 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 43.29. For the most recent quarter (mrq), Quick Ratio is recorded 2.47 and its Current Ratio is at 2.47. In the meantime, Its Debt-to-Equity ratio is 0.31 whereas as Long-Term Debt/Eq ratio is at 0.30.
Robert W. Baird Downgraded its Outperform to Neutral on July 24, 2023, while the target price for the stock was maintained at $13.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 24 when SEA VII Management, LLC sold 6,656 shares for $9.39 per share. The transaction valued at 62,500 led to the insider holds 1,441,657 shares of the business.
SEA VII Management, LLC sold 6,240 shares of DH for $56,846 on May 12. The Director now owns 1,743,478 shares after completing the transaction at $9.11 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DH now has a Market Capitalization of 1.08B and an Enterprise Value of 1.05B. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.40 while its Price-to-Book (P/B) ratio in mrq is 1.25. Its current Enterprise Value per Revenue stands at 4.26 whereas that against EBITDA is -4.34.
Stock Price History:
Over the past 52 weeks, DH has reached a high of $12.45, while it has fallen to a 52-week low of $5.53. The 50-Day Moving Average of the stock is 9.26, while the 200-Day Moving Average is calculated to be 9.19.
Shares Statistics:
DH traded an average of 613.85K shares per day over the past three months and 521.1k shares per day over the past ten days. A total of 105.14M shares are outstanding, with a floating share count of 46.91M. Insiders hold about 59.66% of the company’s shares, while institutions hold 45.26% stake in the company. Shares short for DH as of Jan 31, 2024 were 4.14M with a Short Ratio of 6.75, compared to 5.95M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 3.56% and a Short% of Float of 7.81%.
Earnings Estimates
The firm’s stock currently is rated by 12 analysts. On average, analysts expect EPS of $0.08 for the current quarter, with a high estimate of $0.09 and a low estimate of $0.06, while EPS last year was $0.07. The consensus estimate for the next quarter is $0.07, with high estimates of $0.08 and low estimates of $0.06.
Analysts are recommending an EPS of between $0.32 and $0.29 for the fiscal current year, implying an average EPS of $0.31. EPS for the following year is $0.32, with 12 analysts recommending between $0.34 and $0.3.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 12 analysts. It ranges from a high estimate of $66.17M to a low estimate of $65.85M. As of the current estimate, Definitive Healthcare Corp’s year-ago sales were $60.6M, an estimated increase of 8.90% from the year-ago figure. For the next quarter, 8 analysts are estimating revenue of $65.78M, an increase of 11.10% over than the figure of $8.90% in the same quarter last year. There is a high estimate of $69.93M for the next quarter, whereas the lowest estimate is $63.7M.
A total of 13 analysts have provided revenue estimates for DH’s current fiscal year. The highest revenue estimate was $252M, while the lowest revenue estimate was $251M, resulting in an average revenue estimate of $251.5M. In the same quarter a year ago, actual revenue was $222.65M, up 13.00% from the average estimate. Based on 13 analysts’ estimates, the company’s revenue will be $270.3M in the next fiscal year. The high estimate is $282.8M and the low estimate is $266M. The average revenue growth estimate for next year is up 7.50% from the average revenue estimate for this year.
